Skip to main content
Delta Life Science

Antibody titer, active concentration and host cell protein assay, on one label-free method

Titer, potency, a host cell protein assay and comparability are usually four assays on four platforms, each with its own standard curve and its own reagents, and none of them transfers cleanly to the next stage.
Up to 768 samples on the inQuiQ768
Affinity range from 10 pM to 10 mM
From 30 µL of sample per injection

Where process and QC scientists use label-free binding analysis

Label-free interaction analysis measures real-time binding of unmodified molecules, enabling active concentration, binding kinetics, and batch-to-batch comparability without labels or secondary antibodies.

Upstream antibody titer measurement

Titer determination and IgG quantification through the bioreactor run.

Measure straight from clarified cell culture supernatant.

cell culture supernatant

Clone and cell line selection

Rank clones on what they actually produce.

Cell line screening on titer and on binding activity across candidate lines.

clone selection

Downstream monitoring and host cell protein assay

Follow the product through capture and polishing.

Check binding activity and run HCP quantification after Protein A, ion exchange, and SEC.

quality control

Potency and protein concentration determination

Confirm identity, and that the product still engages its target.

Active concentration reports function, not total protein mass.

active concentration

Biosimilar comparability and batch release testing

Run candidate and reference standard on the same chip.

Compare ka, kd, and KD side by side across lots.

reference standard

Benefits of the inQuiQ in bioprocessing

01 / 04

One injection, four channels, sixteen sensors

Four independently addressable flow channels, each carrying four sensors, with the sample flowing through the channels in series.

30 µL minimumsequential flow paths
In-flow immobilization
Spotter immobilization

Run a plate of batches without touching it

The inQuiQ768 autosampler takes 2×96 or 2×384 well plates and injects one sample after another. Every batch meets the same surface under the same conditions.

2×96 wells2×384 wells
one plate, sequential injections

Measure what still binds, not just what is there

Total protein counts all protein. Reference standards convert binding to active concentration, showing only target-binding protein.

standard curvepotency
response read against a standard curve

Put the reference standard next to the lot

Immobilize reference material alongside candidate lots and inject once. Read up to 16 targets and controls from a single chip for direct comparability.

reference standard
in trend
lot A
in trend
lot B
shifted
16 sensors (spotter required)
reference and lot, same axes

How label-free analysis works

Every measurement follows the same steps, whatever the stage. A capture ligand is held on the sensor, the sample flows past, and the response is recorded through the whole injection rather than at the end.

Ligand immobilization

The capture ligand goes on the sensor surface first.

For antibody titer and active concentration assays, Protein A, the antigen, or a receptor is coupled once and the same surface then serves every batch. Ligand density is set low enough that titer readings are not limited by transport to the surface.

  • Protein A
  • capture ligand
  • ligand density

Deactivation

Unused activated sites are switched off before the first supernatant arrives.

Cell culture supernatant carries host cell protein and media components. Deactivation, together with the antifouling hydrogel, keeps those out of the sensorgram as non-specific binding.

  • deactivation
  • host cell protein
  • non-specific binding

Association

The sample flows across the surface and the response climbs.

In bioprocessing kinetics analysis the association phase gives kon and, read against a standard curve, the active concentration of product in the sample. Supernatant is clarified through a 0.22 µm filter before injection.

  • active concentration
  • standard curve
  • kon

Dissociation

Buffer replaces the sample and the response falls as the complex comes apart.

The dissociation phase gives koff, and kon with koff gives KD. Comparing those three numbers lot to lot is how potency, identity, and biosimilarity are tracked from upstream through release testing.

  • koff
  • KD
  • potency
  • comparability

Regeneration

A regeneration buffer returns the sensor to baseline for the next batch.

The capture ligand stays in place, so every lot and the reference standard meet the same surface. On the inQuiQ768 a full plate of batches runs unattended.

  • regeneration
  • reference standard
  • unattended runs
Response (RU) Time

What the inQuiQ does for bioprocessing

Six capabilities, one modular benchtop instrument, in a label-free workflow.

Many lots, one prepared surface

Four channels with in-flow immobilization, or sixteen sensors with a spotter, put batches and controls on the same capture surface.

16 sensors (spotter required) 30 µL

Active concentration, not total mass

A standard curve of the reference material turns binding response into the concentration of product that still engages its target.

standard curve

Clean signal from crude supernatant

The antifouling hydrogel limits non-specific binding, supporting host cell protein detection after 0.22 µm filtration.

0.22 µm filter

Reference standard side by side

Candidate lots and the reference material sit on one chip and meet the same injected sample, so comparability is read from one run.

biosimilarity comparability

The same kinetic method at every stage

The measurement sits at-line, alongside process analytical technology rather than inside the process stream.

kon, koff, KD

Unattended runs on the inQuiQ768

The autosampler takes 2×96 or 2×384 well plates and works through them one injection after another.

2×96 wells 2×384 wells
Explore the inQuiQ768
Start A conversation

Talk to an application scientist

Bring your process step. We will tell you honestly whether label-free is the right method for it, and how the assay would be built.

Ready to see the inQuiQ in action?

Questions researchers ask

Immobilize Protein A or the antigen on the sensor, inject clarified supernatant, and read the binding response against a standard curve of the reference material. An antibody titer assay run this way needs no secondary antibody and no label, and the result is the concentration of antibody that still binds rather than total protein mass.

Usually yes, after clarification through a 0.22 µm filter. The antifouling hydrogel surface limits binding by host cell protein and media components, and a reference channel subtracts what remains. That removes a purification step between the bioreactor and the number. The same chemistry runs the reverse experiment, a host cell protein assay that captures HCP on purpose for host cell protein quantification instead of excluding it.

Usually yes, after clarification through a 0.22 µm filter. The antifouling hydrogel surface limits binding by host cell protein and media components, and a reference channel subtracts what remains. That removes a purification step between the bioreactor and the number.

Put both on the same chip and inject the same sample series. Measuring kon, koff, and KD side by side under identical conditions makes the comparison a single experiment rather than two runs that have to be normalised against each other afterwards.

The inQuiQ768 autosampler holds 2×96 or 2×384 well plates and works through them one injection after another. Samples run in series, never in parallel, so every batch meets the same prepared surface under the same conditions across the sequence.

Not in the in-line sense. Process analytical technology usually means a probe in the stream, Raman or NIR spectroscopy with a multivariate model behind it, reporting continuously without a sample being taken. Label-free binding analysis is at-line: a sample is drawn, clarified through a 0.22 µm filter and injected. What it adds that an in-line probe cannot is a functional number, the concentration of product that still engages its target and the kinetics behind it, measured the same way at every stage. The two answer different questions and a process monitoring strategy can carry both.

Cookie settings

Choose which optional tools we may use. You can change your choice at any time through "Cookie settings" at the bottom of every page. Privacy policy

Strictly necessary

Always on

Needed for the website to work, such as remembering your cookie choice. These cannot be switched off.

  • Cookie consent choice: Stores your consent choice in your browser so we do not ask again on every page.

Privacy-friendly statistics

Always on

Anonymous visitor statistics with little or no privacy impact. IP addresses are anonymised, no cross-site profiles are built, and the data is not shared for other purposes.

  • Matomo: Anonymous visitor statistics with anonymised IP addresses.
  • Ahrefs Web Analytics: Cookie-free visitor statistics. No personal data is collected.

Analytics

Helps us understand how visitors use the site, for example through heatmaps or session recordings. These tools may set cookies and process your IP address.

  • Microsoft Clarity: Heatmaps and session recordings that show how visitors navigate the site. Provider: Microsoft.

Marketing

Used to measure and improve our advertising, for example on Google or LinkedIn. These tools may set cookies and share data with the advertising platform.

  • OpenAI Ads Pixel: Measures the results of ChatGPT advertising campaigns. Provider: OpenAI.

Region detection: IP Geolocation by DB-IP